Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19

Periodic Reporting for period 3 - COVend (Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19)

Reporting period: 2024-08-01 to 2025-07-31